AI-washing – when AI hype becomes a litigation risk
Our IP and technology transactions team advises clients worldwide on structuring, negotiating, and executing complex intellectual property arrangements that drive innovation and commercial success. From day-to-day licensing and commercial agreements to transformative deals that reshape businesses, we deliver what clients value most: the ability to seize opportunity, manage risk, and realise the full commercial potential of their IP assets.
Our team brings extensive experience in standalone IP transactions, intra-company and cross-license agreements, transitional service arrangements, and other commercial agreements.
What sets us apart is our ability to integrate seamlessly with other practice areas across our global platform. We collaborate closely with colleagues in M&A, tax, and regulatory practices. This multidisciplinary approach ensures that every IP transaction is aligned with broader regulatory, commercial, and strategic considerations.
Key contacts
Representative experience
Represented Daiichi Sankyo its collaboration with Merck & Co. to develop and commercialize their U3-1402, DS-6000 and DS-7300 antibody-drug candidates.
Advised a U.S. biotechnology company in collaboration with Chinese company and transfer of transgenic technology to Chinese-U.S. joint venture.
Advised Citrine on a drug license-in project with a French biological company, including reviewing its exclusive license agreement and advising on drug patent linkage matters in China.
Advised Tommy John on transactional and strategic advice, and their key commercial arrangements recently leading a worldwide team to advise on an international warehousing and distribution arrangement.
Advised Global cosmetic companies such as Supergoop! and Glo Skin with respect to complex commercial agreements including international distribution and supply chain arrangements.
Represented national REIT in data center value added services commercialization strategy.
Represented public-private partnership in the development and commercialization of a state-wide broadband network.
Advising Sandoz AG on a global collaboration with Biocon Biologics Limited, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology.
Advising a global technology company on its joint venture with a global pharma company to enable the research, development, and commercialization of bioelectronic medicines.
Advised multiple global clients on cross-border contracts, international sales and commercial law, and localization of contracts into national law.
